Form 4 for PCVX Vaxcyte, Inc.
Accepted 2024-09-19 00:00:00 ET · period of report 2024-09-18 · accession 0001649094-24-000071 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-09-19 | 2024-09-18 | PCVX | GUGGENHIME ANDREW | Pres AND CFO | S - Sale+OE | $115.95 | -8,000 | 90.4K | -8% | -$927.6K |
| D | 2024-09-19 | 2024-09-18 | PCVX | GUGGENHIME ANDREW | Pres AND CFO | M - OptEx | $5.35 | +8,000 | 98.4K | +9% | +$42.8K |
| D | 2024-09-19 | 2024-09-18 | PCVX | GUGGENHIME ANDREW | Pres AND CFO | M - OptEx | $0.00 | -8,000 | 320.8K | -2% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-09-18 | S | D | 1,686 | $116.29 | 91,212 | D | — | — | (F3) The price reported is a weighted-average price. The shares were sold at prices ranging from $116.06 to $116.75. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 2 | Common | Common Stock | 2024-09-18 | S | D | 5,485 | $115.60 | 92,898 | D | — | — | (F2) The price reported is a weighted-average price. The shares were sold at prices ranging from $115.06 to $115.95. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 3 | Common | Common Stock | 2024-09-18 | M | A | 8,000 | $5.35 | 98,383 | D | — | — | |
| 4 | Common | Common Stock | 2024-09-18 | S | D | 829 | $117.53 | 90,383 | D | — | — | (F4) The price reported is a weighted-average price. The shares were sold at prices ranging from $117.11 to $117.89. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 5 | Derivative | Stock Option (right to buy) | 2024-09-18 | M | D | 8,000 | $0.00 | 320,827 | D | $5.35 · — to 2030-05-11 | 8,000 Common Stock | (F5) 1/4 of the shares subject to the option vested on May 1, 2021, and 1/48 of the shares vest monthly thereafter. |